Results for the substance milnacipran

Milnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used for the treatment of fibromyalgia and major depressive disorder. It works by increasing the levels of these neurotransmitters in the brain, helping to alleviate pain and depressive symptoms.

The medication is taken orally, usually twice daily, with the dose adjusted based on the patient's response. Common side effects include nausea, dizziness, insomnia, and excessive sweating.

Milnacipran is contraindicated in patients with severe renal impairment, uncontrolled hypertension, or hypersensitivity to the active substance. Its use also requires caution in patients at risk of suicide or with cardiovascular conditions.

This medication is an effective option for managing fibromyalgia and depression, helping to improve patients' quality of life.